Roivant Sciences president and Immunovant CEO Eric Venker sells $7.32 million in Roivant common shares

ROIV•2026-10-30

Roivant Sciences president and Immunovant CEO Eric Venker sold 200,000 Roivant common shares on Oct. 28, 2026, at $36.59 per share, retaining 1,199,154 shares.

1. Share sale

Eric Venker sold 200,000 Roivant Sciences common shares on Oct. 28, 2026, at a reported price of $36.59 per share. He retained direct ownership of 1,199,154 common shares.

Sources

Roivant Sciences president and Immunovant CEO Eric Venker sells $7.32 million in Roivant common shares

Sec

Roivant Sciences president and Immunovant CEO Eric Venker sells $7.32 million in Roivant common shares

1. Share sale

Related News

PodcastOne interim CFO Craig Christensen to leave effective October 30, 2026

Porch Group CFO Shawn Tabak reports sale of 30,000 common shares for $630,738

New Era Energy & Digital files initial beneficial ownership statement for director Trent Yang

Sources

Roivant Sciences president and Immunovant CEO Eric Venker sells $7.32 million in Roivant common shares

Blink Charging Co files for up to $100 million mixed shelf offering

Mohawk Industries board authorizes $500 million share buyback